Goldline Pharmaceutical Limited engages in marketing of pharmaceutical products under the Goldline brand in India. It offers goldline pharma, goldline cardinal, goldline aayushman, goldline inLife, and goldline wellness. The company serves physicians, orthopedics, ENT, chest physicians, general and specialty surgery, gastroenterology, neurology, urology, endocrinologists, cardiologists, general physicians, pediatricians, child specialists, neonatologists, intensivists, critical care consultants, and super specialty surgeons. It sells its products through distributors. The company was incorporated in 2004 and is based in Nagpur, India.
| Current Price | ₹42.40 |
|---|---|
| Market Cap | ₹41 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products |
| P/E Ratio | 7.1 |
| Beta (1Y) | -0.36 |
1. Selling and Distribution of Medicines-100%
Goldline Pharmaceutical Limite is trading at ₹42.40, with a market capitalisation of ₹41 Cr.
Goldline Pharmaceutical Limite operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products).
Goldline Pharmaceutical Limite has a P/E of 7.1.